Description: SINTX Technologies, Inc., formerly Amedica Corporation, is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company is incorporating its silicon nitride technology into components for use in total hip and knee replacement product candidates. The Company markets and sells its products to surgeons and hospitals in the United States, and certain markets in Europe and South America. The Company produces silicon nitride for use in its commercial products and product candidates in the various forms, such as solid silicon nitride, porous silicon nitride, composite silicon nitride and silicon nitride coating.
Home Page: www.sintx.com
SINT Technical Analysis
1885 West 2100 South
Salt Lake City,
UT
84119
United States
Phone:
801 839 3500
Officers
| Name | Title |
|---|---|
| Dr. B. Sonny Bal J.D., M.B.A., M.D., MBA, Ph.D. | Chairman, Pres, CEO & Principal Financial Officer |
| Mr. David Francis O'Brien | Chief Operating Officer |
| Ms. Gina Moss | Director of Operations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5516 |
| Price-to-Sales TTM: | 4.7556 |
| IPO Date: | 2014-02-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 36 |